ZyVersa Therapeutics, Inc.
ZVSA
$0.7151
$0.00711.00%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
4/24/2025
-
GuruFocus
4/24/2025
-
The Fly
4/24/2025
-
GuruFocus
4/24/2025
-
Globe Newswire
4/10/2025
-
Yahoo! Finance: News
4/10/2025
-
Insider Monkey
4/9/2025
-
TipRanks Financial Blog
4/8/2025
-
GuruFocus
4/8/2025
-
GuruFocus
4/8/2025
-
GuruFocus
4/8/2025
-
GuruFocus
4/8/2025
-
Globe Newswire
4/4/2025
-
TipRanks Financial Blog
4/4/2025
-
The Fly
3/29/2025
-
Ticker Report
3/27/2025
-
GuruFocus
3/27/2025
-
The Fly
3/27/2025
-
The Fly
3/27/2025
-
Globe Newswire
3/18/2025
-
GuruFocus
3/18/2025
-
TipRanks Financial Blog
3/18/2025
-
The Fly
3/18/2025
-
Globe Newswire
3/12/2025
-
GuruFocus
3/12/2025
-
The Fly
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
--
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, March 27, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 12 and 16 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
(754) 231-1688
Address
2200 N. Commerce Parkway
Weston, FL 33326
Weston, FL 33326
Country
Year Founded
Business Description
Sector
ZyVersa Therapeutics, Inc. operates as a clinical stage biopharmaceutical company that develops and commercializes products for the treatment of renal and inflammatory diseases. The company...
more